Corbus Pharma (CRBP) Misses Q1 EPS by 16c

Corbus Pharma (NASDAQ: CRBP) reported Q1 EPS of ($0.43), $0.16 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.53 million.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Ocean Power Technologies revises fiscal 2026 results after audit
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c